These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages. Kirchhof B; Sorgente N Dev Ophthalmol; 1989; 16():1-53. PubMed ID: 2676632 [TBL] [Abstract][Full Text] [Related]
3. Vitreous modulation of migration and proliferation of retinal pigment epithelial cells in vitro. Kirchhof B; Kirchhof E; Ryan SJ; Sorgente N Invest Ophthalmol Vis Sci; 1989 Sep; 30(9):1951-7. PubMed ID: 2777515 [TBL] [Abstract][Full Text] [Related]
4. Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Proctor lecture. Machemer R Invest Ophthalmol Vis Sci; 1988 Dec; 29(12):1771-83. PubMed ID: 3056866 [No Abstract] [Full Text] [Related]
12. Proliferative vitreoretinopathy in fundus flavimaculatus. Danis RP; Kuwabara T Am J Ophthalmol; 1992 Jun; 113(6):713-4. PubMed ID: 1598966 [No Abstract] [Full Text] [Related]
13. Quantitative assessment of growth stimulating activity of the vitreous during PVR. Yang CM; Cousins SW Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2436-42. PubMed ID: 1634341 [TBL] [Abstract][Full Text] [Related]
14. Proliferative vitreo-retinal disorders: experimental models in vivo and in vitro. Martini B Acta Ophthalmol Suppl (1985); 1992; (201):1-63. PubMed ID: 1322004 [TBL] [Abstract][Full Text] [Related]
15. The chemoattractant activity of the vitreous to human scleral fibroblasts following retinal detachment and proliferative vitreoretinopathy. Wilson-Holt N; Khaw P; Savage F; Grierson I Br J Ophthalmol; 1992 Mar; 76(3):159-62. PubMed ID: 1540560 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of experimental proliferative vitreoretinopathy in rabbits]. Kuriyama S; Ohuchi T; Okada M; Yamakawa R; Yoshimura N; Honda Y Nippon Ganka Gakkai Zasshi; 1990 Sep; 94(9):792-8. PubMed ID: 2248164 [TBL] [Abstract][Full Text] [Related]
18. The role of breakdown of the blood-retinal barrier in cell-injection models of proliferative vitreoretinopathy. Sen HA; Robertson TJ; Conway BP; Campochiaro PA Arch Ophthalmol; 1988 Sep; 106(9):1291-4. PubMed ID: 3415556 [TBL] [Abstract][Full Text] [Related]
19. [Immunomorphological study of the vitreous body and subretinal fluid in vitreoretinal proliferation]. Baudouin C; Brignole F; Bayle J; Fredj-Reygrobellet D; Lapalus P; Gastaud P J Fr Ophtalmol; 1991; 14(3):147-52. PubMed ID: 1918821 [TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of vitreoretinal proliferation and traction: a working hypothesis. Weller M; Heimann K; Wiedemann P Med Hypotheses; 1990 Feb; 31(2):157-9. PubMed ID: 2325589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]